Evotec SE

EVO

----

Current ValuationThe current P/E ratio is -2.33, above the reasonable range, cheaper than 0.89% of the time in the past 3 years, and the industry ranks 30/58, the industry Median -2.31.

-2.33xP/E

Stock price$1.50Earnings per share$-0.64

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x40x80x120x160x200x

P/E ratio
Name/Symbol
LZAGYUSLonza	-388.29x	--	$53.46B
CRLUSCharles River Laboratorie	-69.14x	238.50%	$16.49B
TEMUSTempus AI	-47.68x	1.11%	$12.13B
AVTRUSAvantor	-20.23x	144.28%	$11.69B
TXGUS10X Genomics	-124.09x	108.91%	$9.32B
BRKRUSBruker	-82.08x	7.71%	$8.77B
ADPTUSAdaptive Biotechnologies	-63.76x	38.37%	$4.07B
ABCLUSAbcellera Biologics	-23.26x	36.29%	$3.83B
FTREUSFortrea	-26.38x	93.77%	$2.25B
ALMRUSAlamar Biosciences	-42.88x	80.56%	$2.13B
MRVIUSMaravai LifeSciences	-24.56x	64.44%	$1.90B
PSNLUSPersonalis	-15.79x	18.96%	$1.69B
AZTAUSAzenta	-13.01x	176.92%	$1.60B
CYRXUSCryoport	-20.07x	156.25%	$910.67M
CTKBUSCytek Biosciences	-9.02x	33.98%	$726.61M
OABIUSOmniAb	-15.30x	35.96%	$677.52M
DNAUSGinkgo Bioworks	-2.31x	35.20%	$672.73M
PACBUSPacific Biosc California	-4.99x	75.55%	$655.85M
EVOUSEvotec SE	-2.33x	385.41%	$532.81M
NAUTUSNautilus Biotechnology	-7.29x	9.04%	$412.31M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.